Skip to main content
Erschienen in: Archives of Dermatological Research 8/2007

01.01.2007 | Original Paper

Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma

verfasst von: Rotraut Mössner, Nils Anders, Inke R. König, Ullrich Krüger, Diane Schmidt, Carola Berking, Andreas Ziegler, Jürgen Brockmöller, Rolf Kaiser, Matthias Volkenandt, Götz A. Westphal, Kristian Reich

Erschienen in: Archives of Dermatological Research | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Variations in the melanocortin-1 receptor (MC1R) and in the glutathione-S transferase genes mu1 (GSTM1) and theta 1 (GSTT1) have been reported to influence UV sensitivity and melanoma risk. MC1R is one of the major genes that determine skin pigmentation because the melanocortin-1 receptor regulates eumelanin synthesis. GSTT1 and GSTM1 are enzymes expressed in the skin that detoxify products of oxidative stress reactions caused by UV irradiation. In this study variations in the MC1R, GSTM1 and T1 genes were analyzed in 347 healthy subjects and 322 patients with cutaneous malignant melanoma by direct cycle sequencing, RFLP and multiplex PCR. Important phenotypic characteristics of the study participants were obtained to assess whether genetic associations occurred independently of phenotypic risk factors for melanoma. We found an association of the MC1R D84E and R151C polymorphisms with melanoma (odds ratios for carriage of the rare allele 4.96, 95% CI [1.06–23.13], P = 0.032, and 1.69, 95% CI [1.12–2.55], P = 0.013, respectively). Melanoma risk increased with the number of variant MC1R alleles carried by an individual (P = 0.003). In a multivariate model, however, only the D84E polymorphism influenced melanoma risk independently of the risk factors fair skin type, high nevus count and high age (P = 0.047). There was no effect of homozygous GST M1 or T1 deletions on melanoma risk. In contrast to previous data, there was no evidence that GSTM1 deficiency influences melanoma risk in the subgroup of individuals with red or blond hair.
Literatur
1.
3.
Zurück zum Zitat Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, Lucier GW (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect 98:113–117PubMed Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, Lucier GW (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect 98:113–117PubMed
4.
Zurück zum Zitat Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos SS I, Swerdlow AJ, Bishop DT, Newton Bishop JA (2004) An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype. J Invest Dermatol 122:429–432PubMedCrossRef Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos SS I, Swerdlow AJ, Bishop DT, Newton Bishop JA (2004) An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype. J Invest Dermatol 122:429–432PubMedCrossRef
5.
Zurück zum Zitat Blankenburg S, König IR, Mössner R, Laspe P, Thoms KM, Krüger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S (2005) Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 26:1085–1090PubMedCrossRef Blankenburg S, König IR, Mössner R, Laspe P, Thoms KM, Krüger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S (2005) Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 26:1085–1090PubMedCrossRef
6.
Zurück zum Zitat Burchill SA, Ito S, Thody AJ (1993) Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J Endocrinol 137:189–195PubMedCrossRef Burchill SA, Ito S, Thody AJ (1993) Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J Endocrinol 137:189–195PubMedCrossRef
7.
Zurück zum Zitat Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, Garcia-Cabezas MA, Vara JA, Dominguez-Caceres A, Perona R, Gonzalez-Baron M (2004) Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15:707–719PubMedCrossRef Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, Garcia-Cabezas MA, Vara JA, Dominguez-Caceres A, Perona R, Gonzalez-Baron M (2004) Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15:707–719PubMedCrossRef
8.
Zurück zum Zitat Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102:695–699PubMedCrossRef Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102:695–699PubMedCrossRef
9.
Zurück zum Zitat Hill HZ, Hill GJ (2000) UVA, pheomelanin and the carcinogenesis of melanoma. Pigment Cell Res 13:140–144PubMedCrossRef Hill HZ, Hill GJ (2000) UVA, pheomelanin and the carcinogenesis of melanoma. Pigment Cell Res 13:140–144PubMedCrossRef
10.
Zurück zum Zitat Holland EA, Schmid H, Kefford RF, Mann GJ (1999) CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25:339–348PubMedCrossRef Holland EA, Schmid H, Kefford RF, Mann GJ (1999) CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25:339–348PubMedCrossRef
11.
Zurück zum Zitat Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Davies E, Ollier WE, Thomson W, Yengi L, Bath J, Fryer AA, Strange RC (1998) Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 111:218–221PubMedCrossRef Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Davies E, Ollier WE, Thomson W, Yengi L, Bath J, Fryer AA, Strange RC (1998) Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 111:218–221PubMedCrossRef
12.
Zurück zum Zitat Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, I Dos SS, Beswick S, Bishop DT, Newton Bishop JA (2005) No Evidence for BRAF as a melanoma/nevus susceptibility gene. Cancer Epidemiol Biomarkers Prev 14:913–918PubMedCrossRef Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, I Dos SS, Beswick S, Bishop DT, Newton Bishop JA (2005) No Evidence for BRAF as a melanoma/nevus susceptibility gene. Cancer Epidemiol Biomarkers Prev 14:913–918PubMedCrossRef
13.
Zurück zum Zitat Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR (2001) Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 10:509–513PubMed Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR (2001) Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 10:509–513PubMed
14.
Zurück zum Zitat Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294–300PubMedCrossRef Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294–300PubMedCrossRef
15.
Zurück zum Zitat Kerb R, Brockmoller J, Reum T, Roots I (1997) Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 108:229–232PubMedCrossRef Kerb R, Brockmoller J, Reum T, Roots I (1997) Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 108:229–232PubMedCrossRef
16.
Zurück zum Zitat Kerb R, Brockmoller J, Schlagenhaufer R, Sprenger R, Roots I, Brinkmann U (2002) Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity. Am J Pharmacogenomics 2:147–154PubMedCrossRef Kerb R, Brockmoller J, Schlagenhaufer R, Sprenger R, Roots I, Brinkmann U (2002) Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity. Am J Pharmacogenomics 2:147–154PubMedCrossRef
17.
Zurück zum Zitat La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53–60PubMedCrossRef La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53–60PubMedCrossRef
18.
Zurück zum Zitat Lear JT, Smith AG, Strange RC, Fryer AA (2000) Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 142:8–15PubMedCrossRef Lear JT, Smith AG, Strange RC, Fryer AA (2000) Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 142:8–15PubMedCrossRef
19.
Zurück zum Zitat Lee EY, Williamson R, Watt P, Hughes MC, Green AC, Whiteman DC (2006) Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer (in press) Lee EY, Williamson R, Watt P, Hughes MC, Green AC, Whiteman DC (2006) Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer (in press)
20.
Zurück zum Zitat Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkötter C, Armstrong C, Ansel J (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917:232–238PubMedCrossRef Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkötter C, Armstrong C, Ansel J (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917:232–238PubMedCrossRef
21.
Zurück zum Zitat Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, Crickx B, Grandchamp B, Soufir N (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41:e13PubMedCrossRef Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, Crickx B, Grandchamp B, Soufir N (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41:e13PubMedCrossRef
22.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed
23.
Zurück zum Zitat Moral A, Palou J, Lafuente A, Molina R, Piulachs J, Castel T, Trias M (1997) Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. MMM Group. Multidisciplinary Malignant Melanoma Group. Br J Dermatol 136:345–50PubMedCrossRef Moral A, Palou J, Lafuente A, Molina R, Piulachs J, Castel T, Trias M (1997) Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. MMM Group. Multidisciplinary Malignant Melanoma Group. Br J Dermatol 136:345–50PubMedCrossRef
24.
Zurück zum Zitat Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C (2005) Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 16:893–899PubMedCrossRef Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C (2005) Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 16:893–899PubMedCrossRef
25.
Zurück zum Zitat Naysmith L, Waterston K, Ha T, Flanagan N, Bisset Y, Ray A, Wakamatsu K, Ito S, Rees JL (2004) Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J Invest Dermatol 122:423–428PubMedCrossRef Naysmith L, Waterston K, Ha T, Flanagan N, Bisset Y, Ray A, Wakamatsu K, Ito S, Rees JL (2004) Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J Invest Dermatol 122:423–428PubMedCrossRef
26.
Zurück zum Zitat Neumann AG, Nagaeva O, Mandrika I, Petrovska R, Muceniece R, Mincheva-Nilsson L, Wikberg JE (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126:441–446CrossRef Neumann AG, Nagaeva O, Mandrika I, Petrovska R, Muceniece R, Mincheva-Nilsson L, Wikberg JE (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126:441–446CrossRef
27.
Zurück zum Zitat Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176–186PubMedCrossRef Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176–186PubMedCrossRef
28.
Zurück zum Zitat Panizzon RG, Guggisberg D (1999) [Clinical aspects and pathology of melanoma]. Ther Umsch 56:302–308PubMedCrossRef Panizzon RG, Guggisberg D (1999) [Clinical aspects and pathology of melanoma]. Ther Umsch 56:302–308PubMedCrossRef
29.
Zurück zum Zitat Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271–276PubMed Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271–276PubMed
30.
31.
Zurück zum Zitat Reich K, Westphal G, Schulz T, Muller M, Zipprich S, Fuchs T, Hallier E, Neumann C (1999) Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 113:214–220PubMedCrossRef Reich K, Westphal G, Schulz T, Muller M, Zipprich S, Fuchs T, Hallier E, Neumann C (1999) Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 113:214–220PubMedCrossRef
32.
Zurück zum Zitat Robinson SJ, Healy E (2002) Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21:8037–8046PubMedCrossRef Robinson SJ, Healy E (2002) Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21:8037–8046PubMedCrossRef
33.
Zurück zum Zitat Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariats: Parsimonious parametric modelling. Appl Stat 43:429–467CrossRef Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariats: Parsimonious parametric modelling. Appl Stat 43:429–467CrossRef
34.
Zurück zum Zitat Sanchez-Laorden BL, Sanchez-Mas J, Martinez-Alonso E, Martinez-Menarguez JA, Garcia-Borron JC, Jimenez-Cervantes C (2006) Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J Invest Dermatol 126:172–181PubMedCrossRef Sanchez-Laorden BL, Sanchez-Mas J, Martinez-Alonso E, Martinez-Menarguez JA, Garcia-Borron JC, Jimenez-Cervantes C (2006) Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J Invest Dermatol 126:172–181PubMedCrossRef
35.
Zurück zum Zitat Shanley SM, Chenevix-Trench G, Palmer J, Hayward N (1995) Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. Carcinogenesis 16:2003–2004PubMed Shanley SM, Chenevix-Trench G, Palmer J, Hayward N (1995) Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. Carcinogenesis 16:2003–2004PubMed
36.
Zurück zum Zitat Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG (2003) The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266–272PubMedCrossRef Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG (2003) The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266–272PubMedCrossRef
37.
Zurück zum Zitat Sturm RA, Teasdale RD, Box NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277:49–62PubMedCrossRef Sturm RA, Teasdale RD, Box NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277:49–62PubMedCrossRef
38.
Zurück zum Zitat Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW (2001) Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22:403–408PubMedCrossRef Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW (2001) Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22:403–408PubMedCrossRef
39.
Zurück zum Zitat Ziegler AK, König IR (2006) A statistical approach to genetic epidemiology. Concepts and applications. Wiley-VCH, Weinheim Ziegler AK, König IR (2006) A statistical approach to genetic epidemiology. Concepts and applications. Wiley-VCH, Weinheim
Metadaten
Titel
Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma
verfasst von
Rotraut Mössner
Nils Anders
Inke R. König
Ullrich Krüger
Diane Schmidt
Carola Berking
Andreas Ziegler
Jürgen Brockmöller
Rolf Kaiser
Matthias Volkenandt
Götz A. Westphal
Kristian Reich
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 8/2007
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-006-0708-7

Weitere Artikel der Ausgabe 8/2007

Archives of Dermatological Research 8/2007 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.